Gene: MINDY1
Official Full Name: MINDY lysine 48 deubiquitinase 1provided by HGNC
Gene Summary: Enables K48-linked deubiquitinase activity; K48-linked polyubiquitin modification-dependent protein binding activity; and cysteine-type carboxypeptidase activity. Predicted to be involved in proteolysis. Located in nuclear body. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03074 | MINDY1 Knockout cell line (HeLa) | Human | MINDY1 | 1:3~1:6 | Negative | Online Inquiry |
KO03075 | MINDY1 Knockout cell line (HEK293) | Human | MINDY1 | 1:3~1:6 | Negative | Online Inquiry |
KO03076 | MINDY1 Knockout cell line (A549) | Human | MINDY1 | 1:3~1:4 | Negative | Online Inquiry |
MINDY1 Gene Knockout Cell Lines are genetically modified cellular models designed to facilitate in-depth research into the functional role of the MINDY1 gene in various biological processes. Utilizing CRISPR-Cas9 technology, these cell lines enable the precise deletion of the MINDY1 gene, allowing researchers to study the resulting phenotypic changes that can illuminate the gene's role in cellular mechanisms, including autophagy and cellular stress responses.
The primary function of MINDY1 Gene Knockout Cell Lines is to serve as valuable tools in elucidating the molecular pathways influenced by the MINDY1 gene. By knocking out this gene, researchers can observe alterations in cell behavior, proliferation, and stress resilience, thereby providing insight into its potential implications in diseases such as cancer and neurodegenerative disorders. This knockout approach allows for the identification of compensatory mechanisms and the exploration of gene-gene interactions, making these cell lines pivotal for advancing our understanding of gene function in a controlled experimental setup.
In terms of scientific importance, MINDY1 Gene Knockout Cell Lines have vital applications in both fundamental and applied research, fostering discoveries that can lead to new therapeutic strategies. They are particularly advantageous in drug development processes, where understanding cellular responses to pharmacological agents becomes critical. Furthermore, researchers can utilize these cell lines to investigate the role of MINDY1 in pathogenic mechanisms, contributing to the advancement of personalized medicine approaches.
Compared to other knockout systems, MINDY1 Gene Knockout Cell Lines offer enhanced specificity and reliability, thanks to the precision of the CRISPR-Cas9 methodology. They are rigorously validated to ensure reproducibility of results, which minimizes variability and allows for more consistent data collection. Clinicians and researchers can easily incorporate these tools into their existing workflows, facilitating rapid experimentation while enhancing the interpretative power of their findings.
Our commitment to scientific advancement is underscored by our expertise in developing high-quality biological products tailored for the research community. With our MINDY1 Gene Knockout Cell Lines, we empower researchers and clinicians to make groundbreaking discoveries and push the boundaries of genetic research. This product is not just a tool; it is an essential asset for anyone aiming to uncover the complexities of gene function in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.